Dalemans W
SmithKline Beecham Biologicals, Rixensart, Belgium.
Cytotechnology. 1994;16(3):189-94. doi: 10.1007/BF00749907.
The use of cultured cells with the ultimate goal of using the cells or their products for human therapy has experienced an exponential growth during the last decade. Stable cell cultures have been established and genetically modified to obtain high quality products for protein replacement therapy or vaccines. Cells have also been directly isolated from the human organism and, after their expansion in vitro, been retransferred as skin grafts for treatment of burns or for cancer therapy by activated lymphocytes. With the explosive development of molecular biology techniques, it is now possible to genetically modify ex vivo, cells derived from the human body. These modifications should allow targeted expression of therapeutic genes into specific cells which will, upon retransfer to the body, exert their therapeutic action in a diseased organism.
在过去十年中,以将细胞或其产物用于人类治疗为最终目标的培养细胞的应用呈指数级增长。已经建立了稳定的细胞培养物,并对其进行基因改造以获得用于蛋白质替代疗法或疫苗的高质量产品。细胞也已直接从人体中分离出来,在体外扩增后,作为皮肤移植物重新移植用于治疗烧伤或通过活化淋巴细胞进行癌症治疗。随着分子生物学技术的迅猛发展,现在有可能对源自人体的细胞进行离体基因改造。这些改造应能使治疗基因在特定细胞中靶向表达,这些细胞重新移植到体内后,将在患病机体中发挥治疗作用。